Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Here's what to know about our state’s laws, regulations and qualifying conditions, how to pursue a medical card, and how to ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of ...

SolidRun, a leading developer and manufacturer of high-performance System on Module (SOM) solutions, Single Board Computers (SBC) and network edge solutions, today announced the launch of the ...

Elgin detectives were dubious when their chief suggested starting a true crime podcast to help find Karen Schepers. But it ...

The path forward for a medical cannabis bill in the Nebraska Legislature appears more uncertain after a committee chair ...

Max India, NTPC, Phoenix Mills, IRB Infra, Swan Defence, Concord Biotech, Senco Gold, Zee Media, and Jyoti Structures are ...

In the four months leading up to the trial, the patient’s forced vital capacity—a key measure of lung function—declined from 60% to 37%, despite receiving multiple drugs and experimental ...

Neurizon Therapeutics (ASX:NUZ) is targeting amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND ... which is trialling multiple ALS treatment candidates and this ...

Dublin camogie player and May 50K ambassador Emma O’Byrne is encouraging as many people as possible of all abilities and […] ...